Breaking News !!!

MERGER  ANNOUNCEMENT

Helsinki, Finland and Paris, France  –  April 12, 2013

Mobidiag, Genewave, and Amplidiag announce merger to create
a leading innovator in molecular diagnostics

The new Mobidiag to offer integrated, high-multiplex diagnostic tests for infectious diseases

—————————————–

Company

Genewave is a development-stage diagnostics company whose mission is to provide information rapidly to curb the spread of hospital-acquired infections and anti-microbial resistance.

We are developing a small-footprint, inexpensive, and automated diagnostic instrument that will quickly deliver patient-specific information on 50+ genetic markers.  With our on-chip, high-multiplex approach, we expect to offer a higher-performing, lower-cost, and more versatile solution versus bacterial culture and competing approaches in development.